000			01870 a2200541 4500
005			20250513112506.0
264		0	_c19970603
008			199706s 0 0 eng d
022			_a1082-8893
040			_aNLM _beng _cNLM
100	1		_aStraetmans, N
245	0	0	_aEvolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy. _h[electronic resource]
260			_bHematopathology and molecular hematology _c1996
300			_a213-22 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntigens _xbiosynthesis
650	0	4	_aAntigens, CD _xanalysis
650	0	4	_aAntigens, CD34 _xanalysis
650	0	4	_aBone Marrow Examination
650	0	4	_aCytarabine _xtherapeutic use
650	0	4	_aE-Selectin _xanalysis
650	0	4	_aEndothelium _ximmunology
650	0	4	_aFemale
650	0	4	_aFibrosis
650	0	4	_aHLA-DR Antigens _xanalysis
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aIntegrin beta3
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aLectins _xanalysis
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPlant Lectins
650	0	4	_aPlatelet Endothelial Cell Adhesion Molecule-1 _xanalysis
650	0	4	_aPlatelet Membrane Glycoproteins _xanalysis
650	0	4	_aPrimary Myelofibrosis _xdrug therapy
650	0	4	_aReticulin
650	0	4	_aRetrospective Studies
650	0	4	_aStaining and Labeling
650	0	4	_aStromal Cells _xdrug effects
650	0	4	_avon Willebrand Factor _xanalysis
700	1		_aMa, D D
700	1		_aNevell, D F
700	1		_aArthur, C
773	0		_tHematopathology and molecular hematology _gvol. 10 _gno. 4 _gp. 213-22
999			_c9031261 _d9031261